Another new year, another half-billion-biobuck transaction between Insilico Medicine and the Italian drugmaker Menarini Group ...

An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...

A new global competition offering over $500,000 in prizes aims to spur drug discovery breakthroughs for the cancer target ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

During the conferences, Pattern will conduct one-on-one meetings with investors and potential partners, showcasing the company’s 22 oncology pipelines, additional new oncology diagnostic pipelines in ...

Short selling is a strategy where traders profit from the decline in the price of a stock or other securities.

Rising Demand for Targeted Therapies and Advancements in Genomic Technologies Propel the Personalized Medicine Biomarkers market to a 14.54% CAGR ...

New technologies will soon enable routine measurement of other types of biomolecular data beyond genetics. Wearable health devices can continuously monitor heart rate, blood pressure and other ...

BOWLING GREEN, Ky.- As conversations surrounding the causes of cancer continue to rise, more attention is being placed on early detection and prevention. In light of these discussions, New 40 sat down ...

In an age where preventive health care has become a priority for many, early detection of potential health concerns -- ...

Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational ...